Position in LGND
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,736,815
+$1,622,522 QoQ
Shares Held
11,822
+11.6% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#9
of 82 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COOKSON PEIRCE & CO INC holds $47,400,065 across 10 Biotechnology names. LGND ranks #3 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
398,854 | $22,363,743 | |
| 2 | INCY |
Incyte Corp
|
126,885 | $14,383,683 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
This page
|
11,822 | $3,736,815 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
4,898 | $1,820,439 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
104,992 | $1,781,714 | |
| 6 | LEGN |
Legend Biotech Corp
|
30,000 | $866,400 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
100,000 | $785,000 | |
| 8 | CADL |
Candel Therapeutics, Inc.
|
60,000 | $618,000 |
All Filings in LGND
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,736,815 | 11,822 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,114,293 | 10,590 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,918,493 | 10,147 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,729,417 | 9,763 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,089,281 | 9,582 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $937,323 | 8,915 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $819,697 | 7,650 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $489,940 | 4,895 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $281,512 | 3,341 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||